NICE urges CKD testing to cover more people

GPs should be testing for chronic kidney disease (CKD) in patients taking nephrotoxic drugs, those with structural renal disease, and those with a family history of stage five CKD, according to draft NICE guidelines published last week.

This is in addition to checking for the disease in patients with diabetes, hypertension and cardiovascular disease (CVD).

However, the guidelines do not endorse whole-population screening for CKD, as proposed by the prime minister Gordon Brown earlier this year. 

The draft guidance states that in the absence of risk factors ‘age, gender, ethnicity or BMI should not be used as risk markers to test people for CKD'.

This supports recent research that found screening was only of benefit for at-risk patients (GP, 28 Jan 2008).

Comment below and tell us what you think 


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in